Loss of c-IAP2 ubiquitin ligase activity, which occurs in the lymphoma-causing c-IAP2/MALT1 fusion protein, activates non-canonical NF-ÎºB signaling and results in B cell abnormalities characteristic of MALT lymphoma.
